E-LIB Suche - Ergebnisse für: Bhatt, Rupal S

1

Randomized Phase II Study Evaluating the Addition of Pembro..:

Choudhury, Atish D. ; Kwak, Lucia ; Cheung, Alexander...
Cancer Immunology Research. 12 (2024) 6 - p. 704-718 , 2024

Link: https://doi.org/10.1158/..

2

Circulating KIM-1 is a minimally invasive biomarker correla..:

Xu, Wenxin ; Vemula, Sai V ; Niman, Samuel M...
The Oncologist. 28 (2023) Supplement_1 - p. S2-S2 , 2023

Link: https://doi.org/10.1093/..

3

Regulation of HHLA2 expression in kidney cancer and myeloid..:

Shigemura, Tomonari ; Perrot, Nahuel ; Huang, Zimo...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

4

Combining VEGF receptor inhibitors and angiotensin-(1–7) to..:

Walther, Thomas ; Khanna, Prateek ; Bhatt, Rupal S.
Molecular & Cellular Oncology. 8 (2021) 4 - p. , 2021

Link: https://doi.org/10.1080/..

5

Circulating Cell-Free DNA as Biomarker of Taxane Resistance..:

Francini, Edoardo ; Ou, Fang-Shu ; Rhoades, Justin...
Cancers. 13 (2021) 16 - p. 4055 , 2021

Link: https://doi.org/10.3390/..

6

Enzalutamide With Radiation Therapy for Intermediate-Risk P..:

Kaplan, Irving ; Bubley, Glenn J. ; Bhatt, Rupal S....
International Journal of Radiation Oncology*Biology*Physics. 110 (2021) 5 - p. 1416-1422 , 2021

Link: https://doi.org/10.1016/..

7

Plasma cell-free DNA variant analysis compared with methyla..:

Lasseter, Kathryn ; Nassar, Amin H. ; Hamieh, Lana...
Genetics in Medicine. 22 (2020) 8 - p. 1366-1373 , 2020

Link: https://doi.org/10.1038/..

8

Study of Cathepsin B inhibition in VEGFR TKI treated human ..:

Chen, Chun-Hau ; Bhasin, Swati ; Khanna, Prateek...
Oncogenesis. 8 (2019) 3 - p. , 2019

Link: https://doi.org/10.1038/..

9

A phase 2, randomized trial evaluating the combination of d..:

Voss, Martin H. ; Bhatt, Rupal S. ; Vogelzang, Nicholas J....
Cancer. 125 (2019) 14 - p. 2400-2408 , 2019

Link: https://doi.org/10.1002/..

10

A Non-integrating Lentiviral Approach Overcomes Cas9-Induce..:

Hu, Junhui ; Schokrpur, Shiruyeh ; Archang, Maani...
Molecular Therapy - Methods & Clinical Development. 9 (2018) - p. 203-210 , 2018

Link: https://doi.org/10.1016/..

11

Comprehensive Genomic Profiling of Metastatic Tumors in a P..:

Gao, Xin ; Jegede, Opeyemi ; Gray, Connor...
Clinical Genitourinary Cancer. 16 (2018) 5 - p. 341-348 , 2018

Link: https://doi.org/10.1016/..

12

Alpha-fetoprotein (AFP) as tumor marker in a patient with u..:

Melms, Johannes C. ; Thummalapalli, Rohit ; Shaw, Kristin...
Journal for ImmunoTherapy of Cancer. 6 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

13

Differential expression of c-Met between primary and metast..:

Lalani, Aly-Khan A. ; Gray, Kathryn P. ; Albiges, Laurence...
Oncotarget. 8 (2017) 61 - p. 103428-103436 , 2017

Link: https://doi.org/10.18632..

14

A phase 2 study of the sphingosine‐1‐phosphate antibody son..:

Pal, Sumanta K. ; Drabkin, Harry A. ; Reeves, James A....
Cancer. 123 (2016) 4 - p. 576-582 , 2016

Link: https://doi.org/10.1002/..

15

Inhibition of ALK1 signaling with dalantercept combined wit..:

Wang, Xiaoen ; Solban, Nicolas ; Khanna, Prateek...
Oncotarget. 7 (2016) 27 - p. 41857-41869 , 2016

Link: https://doi.org/10.18632..